Uzpharmcontrol
SSV huzuridagi "Farmatsevtika mahsulotlari xavfsizligi markazi" davlat muassasasining rasmiy telegram kanali Telefon: (+99871) 203-01-01 Veb-sayt: www.uzpharm-control.uz Aloqa bot: @uzpharmcontrol_bot
Show more📈 Analytical overview of Telegram channel Uzpharmcontrol
Channel Uzpharmcontrol (@uzpharmcontrol) in the Uzbek language segment is an active participant. Currently, the community unites 12 899 subscribers, ranking 2 008 in the Medicine category and 6 286 in the Uzbekistan region.
📊 Audience metrics and dynamics
Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 12 899 subscribers.
According to the latest data from 26 July, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by -113 over the last 30 days and by -5 over the last 24 hours, overall reach remains high.
- Verification status: Not verified
- Engagement rate (ER): The average audience engagement rate is 31.95%. Within the first 24 hours after publication, content typically collects 22.30% reactions from the total number of subscribers.
- Post reach: On average, each post receives 4 123 views. Within the first day, a publication typically gains 2 878 views.
- Reactions and interaction: The audience actively supports content: the average number of reactions per post is 8.
📝 Description and content policy
The author describes the resource as a platform for expressing subjective opinions:
“SSV huzuridagi "Farmatsevtika mahsulotlari xavfsizligi markazi" davlat muassasasining rasmiy telegram kanali
Telefon: (+99871) 203-01-01
Veb-sayt: www.uzpharm-control.uz
Aloqa bot: @uzpharmcontrol_bot”
Thanks to the high frequency of updates (latest data received on 27 July, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.
Tadbir davomida dori vositalarini davlat ro‘yxatidan o‘tkazishning Vazirlar Mahkamasining 2025-yil 24-noyabrdagi 738-son qarori bilan tasdiqlangan yangi tartibini amaliyotga tatbiq etish masalalari, ushbu jarayonda yuzaga kelayotgan muammolar hamda tadbirkorlik subyektlarini qiziqtirayotgan savollar muhokama qilinadi. Shuningdek, ishtirokchilarning murojaat va takliflari yuzasidan Markaz mutaxassislari tomonidan batafsil tushuntirishlar beriladi.Barcha mahalliy va xorijiy dori vositalari ishlab chiqaruvchilarini ochiq muloqotda faol ishtirok etishga taklif etamiz. Telegram | Facebook | Instagram | Youtube
4 savolga 4 javob: Muhim maʼlumotlar eslatmasi👍 Dori vositalarini xavfsiz qo‘llashda nimalarga e’tibor berish kerak? - Javob 👍 Giyohvandlik vositalari, psixotrop va kuchli ta’sir qiluvchi moddalar ham raqamli markirovkalanadimi? - Javob 👍 Dori vositalari kontrabandasi: Iste’molchi dori vositasining qalbaki emasligini qanday ajratadi? - Javob 👍 Dori vositalarini sifatini nazorat qilishda postmarketing nazorati qanday ahamiyatga ega? - Javob Telegram | Facebook | Instagram | Youtube
Kongressda Markaziy Osiyoning yetakchi farmatsevtika kompaniyalari rahbarlari, investorlar, loyiha tashabbuskorlari, zamonaviy texnologiyalar yetkazib beruvchilari va xalqaro ekspertlar ishtirok etadi. Mazkur xalqaro anjuman ilg‘or tajribalarni almashish, yangi hamkorlik aloqalarini yo‘lga qo‘yish hamda farmatsevtika sohasida investitsion imkoniyatlarni kengaytirishga xizmat qiladi.📊 Sana: 2026-yil 23-sentabr 📊 Manzil: Biopharmacity klasteri (location) Telegram | Facebook | Instagram | Youtube
Muloqot davomida “NIKA PHARM” MCHJ tomonidan davlat roʻyxatidan oʻtkazilganlik guvohnomalarining amal qilish muddatini uzaytirish uchun taqdim etilgan 6 nomdagi dori vositalari hamda “PHARMACOM MEDICINE” MCHJ tomonidan ishlab chiqarilgan 18 nomdagi dori vositalarini davlat roʻyxatidan oʻtkazish va davlat roʻyxatidan oʻtkazilganlik guvohnomalarining amal qilish muddatini uzaytirishga oid taqdim etilgan hujjatlar muhokama qilindi.Uchrashuv yakunida mas’ul mutaxassislar tadbirkorlar tomonidan berilgan savollarga batafsil javob berib, mahalliy ishlab chiqarilgan dori vositalarini ekspertizadan o‘tkazish jarayonida aniqlanayotgan kamchiliklarni o‘z vaqtida bartaraf etish yuzasidan amaliy tavsiya va tushuntirishlar berdilar. Ta’kidlanganidek, bunday muloqotlar mahalliy farmatsevtika ishlab chiqaruvchilari bilan ochiq va samarali hamkorlikni yanada mustahkamlash, dori vositalarini davlat ro‘yxatidan o‘tkazish jarayonlarining shaffofligi va samaradorligini oshirish, shuningdek, hujjatlarni ko‘rib chiqish jarayonlarini yanada soddalashtirishga xizmat qiladi. Telegram | Facebook | Instagram | Youtube
